Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275181 · ClinicalTrials.gov registry record
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
A clinical trial of Prostate Cancer, sponsored by Kansas State University.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT03275181 is a study of Prostate Cancer that has completed, run by Kansas State University. The registered enrollment target is 18 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03275181, a study of Prostate Cancer, has completed, sponsored by Kansas State University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to determine whether androgen deprivation therapy (ADT) decreases left ventricular function in prostate cancer patients. If found successful, this may lead to improved cardiovascular health via treatment and/or lifestyle interventions in prostate cancer populations.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Transthoracic Echocardiography
- DIAGNOSTIC_TEST Arterial blood pressure
- DIAGNOSTIC_TEST Submaximal Exercise
Study Locations (1)
Kansas
- Kansas State University - Clinical Integrative Physiology Laboratory - Manhattan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03275181
The ClinicalTrials.gov registry entry for NCT03275181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Kansas State University, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Transthoracic Echocardiography is the first listed.
NCT03275181 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03275181 about?
NCT03275181 is a clinical study titled "Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer". The aim of this project is to determine whether androgen deprivation therapy (ADT) decreases left ventricular function in prostate cancer patients. If found successful, this may lead to improved cardiovascular health via treatment and/or lifestyle interventions in prostate cancer populations.
What is the current status of trial NCT03275181?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2017-08-01. Estimated completion is 2018-12-31.
What conditions does trial NCT03275181 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03275181?
The interventions under investigation include: Transthoracic Echocardiography (DIAGNOSTIC_TEST), Arterial blood pressure (DIAGNOSTIC_TEST), Submaximal Exercise (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03275181?
This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03275181 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.